Plain-English translation of NCT06943469 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing a partially hydrolyzed infant formula with synbiotics—a combination of helpful bacteria and their food—to see if it can prevent or reduce eczema and other early signs of allergies in newborns. Babies in this study will either receive this special formula, a standard formula without the added ingredients, or be exclusively breastfed. The goal is to understand whether this new formula helps protect babies' skin and reduces their risk of developing allergies.
Eczema and allergies often develop early in infancy and can be the beginning of a lifelong pattern of allergic problems. This trial exists to find out whether introducing beneficial bacteria and specific formula ingredients early in life might help prevent these allergic skin problems before they start, especially in babies whose parents or siblings have allergies.
You likely qualify if…
You likely don't qualify if…
If your baby is enrolled, you will be assigned to one of three groups: either the special formula with synbiotics, a standard infant formula without added ingredients, or exclusive breastfeeding. You will give your baby the assigned formula or continue breastfeeding, and the research team will monitor your baby's skin health and watch for any signs of eczema or allergic reactions over several months. You'll likely have regular check-ins with the study team to measure progress and report on your baby's health.
AI-generated summary from trial data · Jun 3, 2026 · Not medical advice
Belgium
France